Run with caution in the vaccine race

History shows even the most effective vaccines could have unknown side effects

Illustration: Binay Sinha
Premium

Illustration: Binay Sinha

K M Chandrasekhar
On July 2, the Indian Council of Medical Research (ICMR) sprang a surprise. In a letter to officials at 12 hospitals in the country on preliminary tests on a Covid-19 vaccine developed by Bharat Biotech International (BBIL), the director general said, “It is envisaged to launch the vaccine latest by 15 August 2020, after completion of all clinical trials. BBIL is working expeditiously to meet the target, however, final outcome will depend on the cooperation of all clinical trial sites involved in the project.” The letter, which did the rounds on social media, also carried a threat in its last sentence. “Kindly note that non-compliance will be viewed very seriously. Therefore, you are advised to treat the project on highest
Disclaimer: These are personal views of the writer. They do not necessarily reflect the opinion of www.business-standard.com or the Business Standard newspaper

First Published: Jul 06 2020 | 10:08 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com